CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 1 of 1
Non-Antibody Products
Page 1,284 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Z-AEVD-FMK | An irreversible inhibitor of caspase-10 and related caspases that at 10 &m… | 500 µg | 14987-500 | More Info |
| Zafirlukast | A CysLT1 receptor antagonist (IC50 = 0.014 µM in a cell-based calciu… | 10 mg | 10008282-10 | More Info |
| Zafirlukast | A CysLT1 receptor antagonist (IC50 = 0.014 µM in a cell-based calciu… | 100 mg | 10008282-100 | More Info |
| Zafirlukast | A CysLT1 receptor antagonist (IC50 = 0.014 µM in a cell-based calciu… | 1000 mg | 10008282-1 | More Info |
| Zafirlukast | A CysLT1 receptor antagonist (IC50 = 0.014 µM in a cell-based calciu… | 500 mg | 10008282-500 | More Info |
| (Z-Ala-Ala-Ala-Ala)2Rh110 | A sensitive fluorogenic elastase substrate that is selectively cleaved by… | 1 mg | 11675-1 | More Info |
| (Z-Ala-Ala-Ala-Ala)2Rh110 | A sensitive fluorogenic elastase substrate that is selectively cleaved by… | 10 mg | 11675-10 | More Info |
| (Z-Ala-Ala-Ala-Ala)2Rh110 | A sensitive fluorogenic elastase substrate that is selectively cleaved by… | 5 mg | 11675-5 | More Info |
| Zalcitabine | A NRTI; reduces the replication of laboratory-adapted and clinical isolate… | 100 mg | 16019-100 | More Info |
| Zalcitabine | A NRTI; reduces the replication of laboratory-adapted and clinical isolate… | 25 mg | 16019-25 | More Info |
| Zalcitabine | A NRTI; reduces the replication of laboratory-adapted and clinical isolate… | 250 mg | 16019-250 | More Info |
| Zalcitabine | A NRTI; reduces the replication of laboratory-adapted and clinical isolate… | 500 mg | 16019-500 | More Info |
| Zaltoprofen | An NSAID that displays slight preferential inhibition for COX-2 (IC50s = 1… | 10 mg | 14662-10 | More Info |
| Zaltoprofen | An NSAID that displays slight preferential inhibition for COX-2 (IC50s = 1… | 100 mg | 14662-100 | More Info |
| Zaltoprofen | An NSAID that displays slight preferential inhibition for COX-2 (IC50s = 1… | 250 mg | 14662-250 | More Info |
| Zaltoprofen | An NSAID that displays slight preferential inhibition for COX-2 (IC50s = 1… | 50 mg | 14662-50 | More Info |
| Zamifenacin (fumarate) | An antagonist of M3 muscarinic acetylcholine receptors (Ki = 10 nM for the… | 1 mg | 32848-1 | More Info |
| Zamifenacin (fumarate) | An antagonist of M3 muscarinic acetylcholine receptors (Ki = 10 nM for the… | 10 mg | 32848-10 | More Info |
| Zamifenacin (fumarate) | An antagonist of M3 muscarinic acetylcholine receptors (Ki = 10 nM for the… | 5 mg | 32848-5 | More Info |
| Zanamivir | An inhibitor of influenza neuraminidase; inhibits neuraminidase activity i… | 1 mg | 15123-1 | More Info |
| Zanamivir | An inhibitor of influenza neuraminidase; inhibits neuraminidase activity i… | 10 mg | 15123-10 | More Info |
| Zanamivir | An inhibitor of influenza neuraminidase; inhibits neuraminidase activity i… | 25 mg | 15123-25 | More Info |
| Zanamivir | An inhibitor of influenza neuraminidase; inhibits neuraminidase activity i… | 5 mg | 15123-5 | More Info |
| Zanamivir-13C,15N2 (hydrate) | An internal standard for the quantification of zanamivir by GC- or LC-MS | 250 µg | 30733-250 | More Info |
| Zanubrutinib | A potent and covalent BTK inhibitor (IC50 = 0.3 nM); selective for BTK ove… | 1 mg | 28924-1 | More Info |
| Zanubrutinib | A potent and covalent BTK inhibitor (IC50 = 0.3 nM); selective for BTK ove… | 10 mg | 28924-10 | More Info |
| Zanubrutinib | A potent and covalent BTK inhibitor (IC50 = 0.3 nM); selective for BTK ove… | 25 mg | 28924-25 | More Info |
| Zanubrutinib | A potent and covalent BTK inhibitor (IC50 = 0.3 nM); selective for BTK ove… | 5 mg | 28924-5 | More Info |
| Zapnometinib | A MEK inhibitor (IC50 = 5.73 nM) and an active metabolite of CI-1040; redu… | 10 mg | 38517-10 | More Info |
| Zapnometinib | A MEK inhibitor (IC50 = 5.73 nM) and an active metabolite of CI-1040; redu… | 25 mg | 38517-25 | More Info |
| Zapnometinib | A MEK inhibitor (IC50 = 5.73 nM) and an active metabolite of CI-1040; redu… | 5 mg | 38517-5 | More Info |
| Zapnometinib | A MEK inhibitor (IC50 = 5.73 nM) and an active metabolite of CI-1040; redu… | 50 mg | 38517-50 | More Info |
| Zaprinast | A cGMP phosphodiesterase inhibitor (IC50s = 0.5-0.76 and 0.15 µM for… | 10 mg | 10010421-10 | More Info |
| Zaprinast | A cGMP phosphodiesterase inhibitor (IC50s = 0.5-0.76 and 0.15 µM for… | 100 mg | 10010421-100 | More Info |
| Zaprinast | A cGMP phosphodiesterase inhibitor (IC50s = 0.5-0.76 and 0.15 µM for… | 250 mg | 10010421-250 | More Info |
| Zaprinast | A cGMP phosphodiesterase inhibitor (IC50s = 0.5-0.76 and 0.15 µM for… | 50 mg | 10010421-50 | More Info |
| Zaragozic Acid A | A reversible competitive inhibitor of squalene synthase (Ki = 78 pM in vit… | 1 mg | 17452-1 | More Info |
| Zaragozic Acid A | A reversible competitive inhibitor of squalene synthase (Ki = 78 pM in vit… | 5 mg | 17452-5 | More Info |
| Zardaverine | A dual inhibitor of PDE3 and PDE4 (IC50s = 0.617 and 1.738 µM, respe… | 1 mg | 29685-1 | More Info |
| Zardaverine | A dual inhibitor of PDE3 and PDE4 (IC50s = 0.617 and 1.738 µM, respe… | 10 mg | 29685-10 | More Info |
| Zardaverine | A dual inhibitor of PDE3 and PDE4 (IC50s = 0.617 and 1.738 µM, respe… | 25 mg | 29685-25 | More Info |
| Zardaverine | A dual inhibitor of PDE3 and PDE4 (IC50s = 0.617 and 1.738 µM, respe… | 5 mg | 29685-5 | More Info |
| Z-Asp-CH2-DCB | A pan-caspase inhibitor that blocks apoptosis, prevents the production of… | 10 mg | 15143-10 | More Info |
| Z-Asp-CH2-DCB | A pan-caspase inhibitor that blocks apoptosis, prevents the production of… | 25 mg | 15143-25 | More Info |
| Z-Asp-CH2-DCB | A pan-caspase inhibitor that blocks apoptosis, prevents the production of… | 5 mg | 15143-5 | More Info |
| Z-Asp-CH2-DCB | A pan-caspase inhibitor that blocks apoptosis, prevents the production of… | 50 mg | 15143-50 | More Info |
| Zatebradine (hydrochloride) | Blocks If currents through HCN channels in sinoatrial node cells (IC50s =… | 10 mg | 18608-10 | More Info |
| Zatebradine (hydrochloride) | Blocks If currents through HCN channels in sinoatrial node cells (IC50s =… | 25 mg | 18608-25 | More Info |
| Zatebradine (hydrochloride) | Blocks If currents through HCN channels in sinoatrial node cells (IC50s =… | 5 mg | 18608-5 | More Info |
| Zatebradine (hydrochloride) | Blocks If currents through HCN channels in sinoatrial node cells (IC50s =… | 50 mg | 18608-50 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile